Psoriasis Treatment Advice

Scalp psoriasis is when the psoriasis appears on the scalp of the head, and it can either occur only on the scalp alone or the scalp and parts of the body as well. Scalp involvement is often accompanied by involvement in the gluteal fold of the buttocks. Read more  

Learning about, living with and seeking a cure for psoriasis -- in layman's terms.  

Psoriasis is a skin disorder that we often do not associated with fingernail growth but can adversely affect the health of your hands.Contributor: Christine CadenaPublished: Dec 16, 2009  

I have P since I was nine and am sick and tired of spending money on P treatment. Its about time to stop spending money and start making money just in case I need to hire two care taker later on in my life. ...  

Celgene reports positive results from Phase IIb psoriasis trialTrading Markets (press release)"Importantly, the results of this study suggest that apremilast may become a new oral therapy for psoriasis with a unique balance of safety, ...  

Clinical AdvisorBiologic for treatment of plaque psoriasisClinical AdvisorIndication: Moderate-to- severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy. Pharmacology: Ustekinumab is a human ...  

John DelleCave knows how difficult it can be to live with psoriasis. That's because he does it every day. He's had the disease, which causes scaly patches on his skin and scalp, for years. DelleCave h...  

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company's PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis. Dr. Craig Dees, Ph.D., CEO of Provectus said, "We are excited by the positive data reported from both of the Phase 2 clinical trials for PH-10. As previously announced, our...  

Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy also known as phototherapy.  

But remember, only buy wigs, I think that you feel about yourself while making good use of friends im known as the hairline on hair loss them too. Wigs to make a web site to improve how you can be quite different from a wig expert. ...  

Generic drug developer Perrigo Co. said Wednesday it is being sued by Galderma and Dermalogix over plans to make a version of the plaque psoriasis treatment, Clobex spray. Perrigo has asked the Food and Drug Administration to approve a generic version of the... Food and Drug Administration - Psoriasis - Health - Perrigo - Perrigo Co  

MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--PhotoMedex, Inc. (Nasdaq: PHMD) a leading provider of advanced dermatology, clinical skincare and medical laser products, is hosting a free seminar in Indianapolis, IN on November 17, 2009. The seminar, “A Win for Your Skin in the Daily Fight Against Psoriasis with XTRAC® Excimer Lasers,” is open to the public and will feature three prominent local physicians (from the Dermatology Group LLC and The...  

On World Psoriasis Day the International Psoriasis Council Hosts Latin ...Reuters"Members of IPC are very active in psoriasis research, which has significantly advanced the care of patients with psoriasis and psoriatic arthritis in the ...and more »  

Johnson & Johnson recently launched Stelara for the treatment of adult patients (18 years or older) with moderate to severe plaque psoriasis. Although Stelara is entering a crowded treatment room for psoriasis, this first-in-class interleukin (IL) inhibitor could still put the "no more tears" back in J's future -- if successfully marketed to specialists, in particular dermatologists, as it is a novel and less cumbersome injectable than...  

In September 2009, Amgen decided to withdraw application for expanded use of its biologic tumor necrosis factor (TNF) blocking agent etanercept (Enbrel) in pediatric patients with moderate-to-severe psoriasis.